時間 | 主題 | ||||
---|---|---|---|---|---|
PD05-1: Factor evaluation of chemotherapy-naïve Enzalutamide on castration - resistant prostate cancer patients—Taiwanese cohort
講者:
余秉軒
座長:
張英勛, 林子平 |
余秉軒 |
張英勛, 林子平 |
|||
PD05-2: Tumor volume, time to PSA nadir and PSA decline rate influence outcomes in metastatic prostate cancer receiving androgen deprivation therapy
講者:
林晏頎
座長:
張英勛, 林子平 |
林晏頎 |
張英勛, 林子平 |
|||
PD05-3: Pathological node-positive renal cell carcinoma is associated with worse survival outcome: A recall for TMN staging revision
講者:
陳思遠
座長:
張英勛, 林子平 |
陳思遠 |
張英勛, 林子平 |
|||
PD05-4: Active contour model of machine learning to evlauate the kidney cancer
講者:
盧致誠
座長:
張英勛, 林子平 |
盧致誠 |
張英勛, 林子平 |
|||
PD05-5: The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: Systemic review and meta-analysis
講者:
謝博彥
座長:
張英勛, 林子平 |
謝博彥 |
張英勛, 林子平 |
|||
PD05-6: Combined immune checkpoint inhibitors in the frontline treatment of metastatic renal cell carcinoma—a real-world experience
講者:
陳鵬
座長:
張英勛, 林子平 |
陳鵬 |
張英勛, 林子平 |